The levels of β2m mRNA are significantly higher in metastatic than in non-metastatic forms of medulloblastoma [35], suggesting a potential association of β2m and/or HLA class I with aggressive behavior and poor prognosis in this type of tumor, as well. The gene discussed is B2M; the disease is medulloblastoma.